达安基因:取得一个医疗器械注册证

智通财经
Aug 18
【达安基因:取得一个医疗器械注册证】达安基因公告,近日,公司取得国家药品监督管理局颁发的医疗器械注册证一个,具体为:医疗器械名称:人副流感病毒核酸检测试剂盒,注册证编号:国械注准 20263401731。有效期自批准之日起至 2031 年8 月16 日。预期用途:本产品用于定性检测人口咽拭子中人副流感病毒 RNA,包括人副流感病毒Ⅰ型、人副流感病毒Ⅱ型、人副流感病毒Ⅲ型和人副流感病毒Ⅳ型,本试剂盒的检测结果不区分副流感病毒型别。上述医疗器械注册证的取得丰富了公司的产品组合,拓宽了公司产品的应用领域。目前,上述产品尚处于市场开发阶段,市场需求存在不确定性,请广大投资者注意投资风险。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10